IN2012DN04085A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04085A
IN2012DN04085A IN4085DEN2012A IN2012DN04085A IN 2012DN04085 A IN2012DN04085 A IN 2012DN04085A IN 4085DEN2012 A IN4085DEN2012 A IN 4085DEN2012A IN 2012DN04085 A IN2012DN04085 A IN 2012DN04085A
Authority
IN
India
Prior art keywords
minutes
relates
enhancing muscle
repeated sprints
protein
Prior art date
Application number
Other languages
English (en)
Inventor
Daniel Ryan Moore
Eric Zaltas
John Alan Hawley
Louise Mary Burke
Trent Stellingwerff
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN04085A publication Critical patent/IN2012DN04085A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN4085DEN2012 2009-11-29 2010-11-29 IN2012DN04085A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09177423.2A EP2327316B1 (fr) 2009-11-29 2009-11-29 Procédé d'amélioration de la synthèse de protéines musculaires
PCT/EP2010/068439 WO2011064373A1 (fr) 2009-11-29 2010-11-29 Procédé d'amélioration de la synthèse des protéines musculaires

Publications (1)

Publication Number Publication Date
IN2012DN04085A true IN2012DN04085A (fr) 2015-08-07

Family

ID=42135915

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4085DEN2012 IN2012DN04085A (fr) 2009-11-29 2010-11-29

Country Status (13)

Country Link
US (1) US20130203645A1 (fr)
EP (1) EP2327316B1 (fr)
JP (1) JP5810429B2 (fr)
CN (1) CN102665445B (fr)
AU (1) AU2010323089B2 (fr)
BR (1) BR112012012811A2 (fr)
CA (1) CA2781764A1 (fr)
IN (1) IN2012DN04085A (fr)
MX (1) MX2012005646A (fr)
NZ (1) NZ600094A (fr)
PH (1) PH12012500875A1 (fr)
RU (1) RU2503269C1 (fr)
WO (1) WO2011064373A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
WO2013188422A1 (fr) * 2012-06-11 2013-12-19 Nu Science Laboratories, Inc. Produits nutritionnels et procédés pour améliorer la performance d'exercices physiques
HK1214739A1 (zh) * 2012-11-20 2016-09-30 Axcella Health Inc. 工程化的分泌蛋白质和方法
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2014138304A1 (fr) 2013-03-08 2014-09-12 Axiom Foods, Inc., Suppléments à base de protéine de riz
EP2983530A1 (fr) * 2013-03-26 2016-02-17 Premier Nutrition Corporation Procédé d'amélioration de la synthèse de protéines musculaires après un entraînement concomitant
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
WO2015040533A1 (fr) * 2013-09-19 2015-03-26 Premier Nutrition Corporation Procédé d'amélioration de la synthèse de protéines musculaires durant un déficit énergétique
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3634155A4 (fr) 2017-05-12 2021-02-17 Axiom Foods Inc. Produits de riz et systèmes et procédés de fabrication de ceux-ci
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075713C (zh) * 1996-05-23 2001-12-05 大塚制药株式会社 降低身体脂肪含量和改善身体组成的食物组合物及其方法
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
EP1112693B1 (fr) * 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comportant le matériel d'hydrate de carbone et de peptide et son utilisation comme supplément d'énergie après ou pendant l'exercice physique ou comme aliment métabolique pour l'administration orale
AU2002243267A1 (en) * 2000-10-27 2002-06-24 Mannatech, Inc. Dietary supplement compositions
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20030064134A1 (en) * 2001-10-03 2003-04-03 Eastman Outdoors Kit, system and method for preparing home-made nutritional food items
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
JP2005070853A (ja) * 2003-08-26 2005-03-17 Md 21:Kk ダイエットプログラムのメニュー作成方法及びそのシステム
US7205018B2 (en) * 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
EP1904070A4 (fr) * 2005-07-07 2009-09-02 H3 Formulations Ltd Supplément alimentaire pour l amélioration de la masse musculaire squelettique, la diminution de la dégradation des protéines musculaires, la diminution du nombre de voies du catabolisme musculaire et la diminution du catabolisme des cellules musculaires.
WO2007056176A2 (fr) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions visant a prevenir et reduire les courbatures du lendemain
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
WO2007133642A1 (fr) * 2006-05-11 2007-11-22 Garcia Ramon D Boisson pour sportif contenant des acides aminés et des glucides
RU2306720C1 (ru) * 2006-07-06 2007-09-27 Энвер Саидович Токаев Продукт "спортамин" для питания спортсменов
US20090169684A1 (en) * 2007-12-29 2009-07-02 Cresta Andrea K Fitness and exercise enhancing tablet containing protein isolate
EP2098126A1 (fr) * 2008-03-03 2009-09-09 Nestec S.A. Barre de glucide

Also Published As

Publication number Publication date
AU2010323089B2 (en) 2014-07-24
RU2503269C1 (ru) 2014-01-10
JP2013511970A (ja) 2013-04-11
US20130203645A1 (en) 2013-08-08
EP2327316B1 (fr) 2016-11-16
BR112012012811A2 (pt) 2015-09-15
HK1175664A1 (en) 2013-07-12
CN102665445A (zh) 2012-09-12
MX2012005646A (es) 2012-06-13
JP5810429B2 (ja) 2015-11-11
AU2010323089A1 (en) 2012-05-31
CA2781764A1 (fr) 2011-06-03
EP2327316A1 (fr) 2011-06-01
PH12012500875A1 (en) 2013-01-07
CN102665445B (zh) 2015-03-25
NZ600094A (en) 2014-10-31
WO2011064373A1 (fr) 2011-06-03

Similar Documents

Publication Publication Date Title
IN2012DN04085A (fr)
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
MX2010008726A (es) Composiciones y metodos para influir en la recuperacion a partir de actividad fisica intensa.
MX2015013749A (es) Metodos para aumentar la sintesis de proteinas musculares despues de entrenamiento simultáneo.
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
TW201129377A (en) Binding proteins that bind to human FGFR1c, human β-Klotho and both human FGFR1c and human β-Klotho
MY151018A (en) Use of nutritional compositions for preventing disorders
MY163119A (en) Use of tenecteplase for treating acute ischemic stroke
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
NZ724593A (en) Anti-cd70 antibody drug conjugates
MY176679A (en) Use of nutritional compositions for preventing disorders
MX2010004074A (es) Combinacion 059.
WO2010130830A3 (fr) Séquences d'acides aminés dirigées contre la sclérostine et polypeptides comprenant ces dernières pour le traitement de maladies et de pathologies des os
WO2009032888A3 (fr) Compositions s'administrant par voie orale, produits et procédés d'utilisation
EP1670450A4 (fr) Compositions pharmaceutiques et procede d'utilisation de la levodopa et de la carbidopa
WO2010071826A3 (fr) Procédés de traitement d'une maladie liée aux ostéoclastes, composés et compositions pour ceux-ci
BR112014007675A2 (pt) tratamento de doença articular degenerativa
MX353301B (es) Composiciones tripeptidicas y metodos para tratamiento de diabetes.
WO2010019212A3 (fr) Procédés d'amélioration du métabolisme énergétique
WO2009120837A3 (fr) Compositions de peptide riche en leucine et procédés d’isolement
WO2008112840A3 (fr) Nouvelle composition et nouveaux procédés de traitement des maladies immunologiques
WO2010000851A3 (fr) Procédés pour moduler l’angiogenèse via la dystrophine dp71
MX2010001381A (es) Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.
MX2010010177A (es) Fragmentos de beta timosina mejorada.
AU2017221784B2 (en) Novel compositions and methods for the treatment of immune related diseases